Collaboration between pharmaceutical companies and tech firms is accelerating innovation in the commercial pharmaceutical analytics market. Valued at $12.5 billion in 2023, this market thrives on partnerships that combine pharma’s domain expertise with tech’s data capabilities. From AI tool development to cloud infrastructure, these alliances are breaking down silos and delivering...